医学
内科学
肺动脉高压
比例危险模型
危险系数
不利影响
共病
队列研究
队列
前瞻性队列研究
心脏病学
生命银行
纵向研究
肺癌
血液学
生存分析
死亡风险
心力衰竭
肺
试验预测值
危险分层
肺栓塞
混淆
预测值
心血管健康
生物标志物
回顾性队列研究
作者
Fang Zhu,Qian Zhang,Wenqing Lu,Wenjie Cai,Xiao Gu,Jingwen Dong,Hao Hang,Qingquan Luo
标识
DOI:10.1007/s10238-026-02286-1
摘要
To investigate the prevalence and prognostic impact of pulmonary hypertension (PH) in lung cancer (LC) and assess its association with long-term mortality and major adverse cardiac and cerebrovascular events (MACCE). A total of 500,530 participants enrolled in the UK Biobank between 2006 and 2010 were prospectively followed through October 31, 2022. Incident LC cases were identified during follow-up. Overall survival (OS) and MACCE were assessed according to PH status. Time-dependent Cox regression models were used to estimate adjusted hazard ratios (HRs) after controlling for demographic characteristics, smoking status, comorbidities, and histological subtype. During a median follow-up exceeding 12 years, 6,095 participants developed LC. PH was significantly more prevalent among participants with LC than among those without LC. Among patients with LC, PH was associated with significantly increased risks of mortality and MACCE. After multivariable adjustment, PH remained independently associated with adverse outcomes, with progressively greater prognostic impact over time. At 10 years, adjusted HRs were 2.88 for OS and 3.45 for MACCE. PH is an important adverse cardiopulmonary comorbidity in LC and is independently associated with worse long-term survival and cardiovascular outcomes. These findings support the potential value of early recognition and longitudinal cardiopulmonary surveillance for risk stratification and management in patients with LC.
科研通智能强力驱动
Strongly Powered by AbleSci AI